vimarsana.com

Latest Breaking News On - Prapela inc - Page 1 : vimarsana.com

Biddeford infant health startup gets $3 5M NIH grant

The grant, expected to provide $3.5 million over three years, was awarded to support the development and evaluation of Prapela's technology-enabled bassinet pad to treat apnea in preterm newborns.

Tufts medical centerUnited statesRachana singhJohn konsinUniversity of alabama at birminghamSmall business innovative researchPrapela incNational institutes of healthUs food drug administrationNational institutesDrug administrationBreakthrough device designationTufts medical

Prapela receives NIH Grant to improve the treatment of Apnea of Prematurity in collaboration with Tufts Medical Center and the University of Alabama at Birmingham

/PRNewswire/ Prapela, Inc., an infant health company in Biddeford, ME, was awarded a grant through the National Institutes of Health (NIH) Blueprint MedTech.

United statesUniversity of alabamaTufts medical centerUniversity of massachusetts medical schoolHarvard universityUniversity of alabama at birminghamJeremy lechanHannah echolsNamasivayam ambalavananJohn konsinMatt porterRachana singhPaediatr child healthUs food drug administrationNational institutes of healthSaunders electronics

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

/PRNewswire/ Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its.

United statesUniversity of massachusetts medical schoolTufts medical centerQureshi ahmadJohn konsinPediatric device consortiumHuman developmentNational capital consortium for pediatric device innovationPediatric trials network steering committeeDrug administrationPharmaceuticals for childrenUniversity of alabama at birminghamPrapela incNational institute of child healthPrnewswire prapela incDevice designations

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threate.

United statesUniversity of massachusetts medical schoolTufts medical centerJohn konsinHuman developmentPediatric device consortiumNational capital consortium for pediatric device innovationDrug administrationUniversity of alabama at birminghamNational institute of child healthPrnewswire prapela incPrapela incDevice designationsBreakthrough device designationDevice designationNational institute

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

/PRNewswire/ Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its.

United statesUniversity of massachusetts medical schoolTufts medical centerQureshi ahmadJohn konsinPediatric device consortiumHuman developmentNational capital consortium for pediatric device innovationPediatric trials network steering committeeDrug administrationPharmaceuticals for childrenUniversity of alabama at birminghamPrapela incNational institute of child healthPrnewswire prapela incDevice designations

vimarsana © 2020. All Rights Reserved.